265 related articles for article (PubMed ID: 31897951)
1. Quantitative metabolomics of saliva using proton NMR spectroscopy in patients with Parkinson's disease and healthy controls.
Kumari S; Goyal V; Kumaran SS; Dwivedi SN; Srivastava A; Jagannathan NR
Neurol Sci; 2020 May; 41(5):1201-1210. PubMed ID: 31897951
[TBL] [Abstract][Full Text] [Related]
2. Identification of potential urine biomarkers in idiopathic parkinson's disease using NMR.
Kumari S; Kumaran SS; Goyal V; Sharma RK; Sinha N; Dwivedi SN; Srivastava AK; Jagannathan NR
Clin Chim Acta; 2020 Nov; 510():442-449. PubMed ID: 32791135
[TBL] [Abstract][Full Text] [Related]
3. Serum metabolomics study in a group of Parkinson's disease patients from northern India.
Nagesh Babu G; Gupta M; Paliwal VK; Singh S; Chatterji T; Roy R
Clin Chim Acta; 2018 May; 480():214-219. PubMed ID: 29474999
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive metabolic profiling of Parkinson's disease by liquid chromatography-mass spectrometry.
Shao Y; Li T; Liu Z; Wang X; Xu X; Li S; Xu G; Le W
Mol Neurodegener; 2021 Jan; 16(1):4. PubMed ID: 33485385
[TBL] [Abstract][Full Text] [Related]
5. (1)H NMR-based metabolomics study on a goldfish model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Lu Z; Wang J; Li M; Liu Q; Wei D; Yang M; Kong L
Chem Biol Interact; 2014 Nov; 223():18-26. PubMed ID: 25242684
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson's disease.
Weiduschat N; Mao X; Beal MF; Nirenberg MJ; Shungu DC; Henchcliffe C
J Neuroimaging; 2015; 25(1):105-10. PubMed ID: 24325203
[TBL] [Abstract][Full Text] [Related]
7. Potential biomarkers of Parkinson's disease revealed by plasma metabolic profiling.
Zhao H; Wang C; Zhao N; Li W; Yang Z; Liu X; Le W; Zhang X
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():101-108. PubMed ID: 29518718
[TBL] [Abstract][Full Text] [Related]
8. Plasma Metabolic Analysis Reveals the Dysregulation of Short-Chain Fatty Acid Metabolism in Parkinson's Disease.
Qi A; Liu L; Zhang J; Chen S; Xu S; Chen Y; Zhang L; Cai C
Mol Neurobiol; 2023 May; 60(5):2619-2631. PubMed ID: 36690885
[TBL] [Abstract][Full Text] [Related]
9. Biomarker Research in Parkinson's Disease Using Metabolite Profiling.
Havelund JF; Heegaard NHH; Færgeman NJK; Gramsbergen JB
Metabolites; 2017 Aug; 7(3):. PubMed ID: 28800113
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi-Omics.
Tan AH; Chong CW; Lim SY; Yap IKS; Teh CSJ; Loke MF; Song SL; Tan JY; Ang BH; Tan YQ; Kho MT; Bowman J; Mahadeva S; Yong HS; Lang AE
Ann Neurol; 2021 Mar; 89(3):546-559. PubMed ID: 33274480
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Profiling of CSF from People Suffering from Sporadic and LRRK2 Parkinson's Disease: A Pilot Study.
Yilmaz A; Ugur Z; Ustun I; Akyol S; Bahado-Singh RO; Maddens M; Aasly JO; Graham SF
Cells; 2020 Oct; 9(11):. PubMed ID: 33142859
[TBL] [Abstract][Full Text] [Related]
12. LC-MS-based urinary metabolite signatures in idiopathic Parkinson's disease.
Luan H; Liu LF; Meng N; Tang Z; Chua KK; Chen LL; Song JX; Mok VC; Xie LX; Li M; Cai Z
J Proteome Res; 2015 Jan; 14(1):467-78. PubMed ID: 25271123
[TBL] [Abstract][Full Text] [Related]
13. Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson's Disease.
Vivacqua G; Latorre A; Suppa A; Nardi M; Pietracupa S; Mancinelli R; Fabbrini G; Colosimo C; Gaudio E; Berardelli A
PLoS One; 2016; 11(3):e0151156. PubMed ID: 27011009
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease.
Luan H; Liu LF; Tang Z; Zhang M; Chua KK; Song JX; Mok VC; Li M; Cai Z
Sci Rep; 2015 Sep; 5():13888. PubMed ID: 26365159
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Biomarkers of Alzheimer's Disease as Identified in Saliva using 1H NMR-Based Metabolomics.
Yilmaz A; Geddes T; Han B; Bahado-Singh RO; Wilson GD; Imam K; Maddens M; Graham SF
J Alzheimers Dis; 2017; 58(2):355-359. PubMed ID: 28453477
[TBL] [Abstract][Full Text] [Related]
16. Salivary alpha-synuclein in the diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
Vivacqua G; Suppa A; Mancinelli R; Belvisi D; Fabbrini A; Costanzo M; Formica A; Onori P; Fabbrini G; Berardelli A
Parkinsonism Relat Disord; 2019 Jun; 63():143-148. PubMed ID: 30796010
[TBL] [Abstract][Full Text] [Related]
17. Metabolite and peptide levels in plasma and CSF differentiating healthy controls from patients with newly diagnosed Parkinson's disease.
Trupp M; Jonsson P; Ohrfelt A; Zetterberg H; Obudulu O; Malm L; Wuolikainen A; Linder J; Moritz T; Blennow K; Antti H; Forsgren L
J Parkinsons Dis; 2014; 4(3):549-60. PubMed ID: 24927756
[TBL] [Abstract][Full Text] [Related]
18. Post-periodontal surgery propounds early repair salivary biomarkers by
Singh MP; Saxena M; Saimbi CS; Siddiqui MH; Roy R
Metabolomics; 2019 Oct; 15(11):141. PubMed ID: 31612356
[TBL] [Abstract][Full Text] [Related]
19. Review of Metabolomics-Based Biomarker Research for Parkinson's Disease.
Li X; Fan X; Yang H; Liu Y
Mol Neurobiol; 2022 Feb; 59(2):1041-1057. PubMed ID: 34826053
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of the metabolomic profiles of saliva from female orthodontic patients with external apical root resorption.
Zhou J; Hu H; Huang R
Clin Chim Acta; 2018 Mar; 478():188-193. PubMed ID: 29291387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
